| Screening and treatment program to eliminate hepatitis C in Egypt I Waked, G Esmat, A Elsharkawy, M El-Serafy, W Abdel-Razek, R Ghalab, ... New England Journal of Medicine 382 (12), 1166-1174, 2020 | 243 | 2020 |
| Global multi-stakeholder endorsement of the MAFLD definition N Méndez-Sánchez, E Bugianesi, RG Gish, F Lammert, H Tilg, ... The Lancet Gastroenterology & Hepatology 7 (5), 388-390, 2022 | 182 | 2022 |
| Generic daclatasvir plus sofosbuvir, with or without ribavirin, in treatment of chronic hepatitis C: real‐world results from 18 378 patients in Egypt H Omar, W El Akel, T Elbaz, M El Kassas, K Elsaeed, H El Shazly, M Said, ... Alimentary pharmacology & therapeutics 47 (3), 421-431, 2018 | 138 | 2018 |
| Changes in liver stiffness measurements and fibrosis scores following sofosbuvir based treatment regimens without interferon A Elsharkawy, SA Alem, R Fouad, M El Raziky, W El Akel, M Abdo, ... Journal of gastroenterology and hepatology 32 (9), 1624-1630, 2017 | 102 | 2017 |
| Estimation of COVID-19 burden in Egypt M Hassany, W Abdel-Razek, N Asem, M AbdAllah, H Zaid The Lancet Infectious Diseases 20 (8), 896-897, 2020 | 74 | 2020 |
| Impact of different sofosbuvir based treatment regimens on the biochemical profile of chronic hepatitis C genotype 4 patients A Elsharkawy, R Eletreby, R Fouad, Z Soliman, M Abdallah, M Negm, ... Expert review of gastroenterology & hepatology 11 (8), 773-778, 2017 | 49 | 2017 |
| RETRACTED ARTICLE: Efficacy of combined Sofosbuvir and Daclatasvir in the treatment of COVID-19 patients with pneumonia: a multicenter Egyptian study M El-Bendary, S Abd-Elsalam, T Elbaz, W El-Akel, A Cordie, T Elhadidy, ... Expert Review of Anti-infective Therapy 20 (2), 291-295, 2022 | 38 | 2022 |
| Capturing patient experience: a qualitative study of change from NAFLD to MAFLD real-time feedback SA Alem, Y Gaber, M Abdalla, E Said, Y Fouad Journal of Hepatology 74 (5), 1261-1262, 2021 | 32 | 2021 |
| Serum cytokeratin-18 and its relation to liver fibrosis and steatosis diagnosed by FibroScan and controlled attenuation parameter in nonalcoholic fatty liver disease and … SK Darweesh, RA AbdElAziz, DS Abd-ElFatah, NA AbdElazim, SA Fathi, ... European journal of gastroenterology & hepatology 31 (5), 633-641, 2019 | 31 | 2019 |
| Pregnancy outcome of anti‐HCV direct‐acting antivirals: Real‐life data from an Egyptian cohort M AbdAllah, M Alboraie, W Abdel‐Razek, M Hassany, I Ammar, E Kamal, ... Liver International 41 (7), 1494-1497, 2021 | 29 | 2021 |
| High Dose of Silymarin in Patients with Decompensated Liver Disease: A Randomized Controlled Trial WF Fathalah, MAA Abdel Aziz, NH Abou el Soud, MES El Raziky Journal of Interferon & Cytokine Research 37 (11), 480-487, 2017 | 27 | 2017 |
| Pattern and determinants of COVID-19 infection and mortality across countries: An ecological study N Asem, A Ramadan, M Hassany, RM Ghazy, M Abdallah, M Ibrahim, ... Heliyon 7 (7), 2021 | 21 | 2021 |
| Emerging from the screening of 57 million citizens and treating 4 million patients: future strategies to eliminate hepatitis C from Egypt G Esmat, T Elbaz, A Elsharkawy, M Abdullah, M El Kassas Expert review of anti-infective therapy 18 (7), 637-642, 2020 | 15 | 2020 |
| Metabolic-associated fatty liver disease and autoimmune hepatitis: an overlooked interaction Y Gaber, M AbdAllah, A Salama, M Sayed, S Abdel Alem, S Nafady Expert Review of Gastroenterology & Hepatology 15 (10), 1181-1189, 2021 | 11 | 2021 |
| The Metabolic (Dysfunction)-Associated Fatty Liver Disease (MAFLD) and Non-Alcoholic Fatty Liver Disease (NAFLD) Debate: Why the American Association for the Study of Liver … YM Fouad, A Gomaa, RM El Etreby, M AbdAllah, D Attia Medical Science Monitor: International Medical Journal of Experimental and …, 2022 | 9 | 2022 |
| DAAs therapy associated with improved hepatic fibrosis in HCV-GT4 patients co-infected with HIV H El-Garem, M AbdAllah, H Omar, A Cordie, S Abdel Alem, ... Expert review of gastroenterology & hepatology 13 (7), 693-698, 2019 | 9 | 2019 |
| Nationwide hepatitis C virus screening and treatment of adolescents in Egyptian schools E Kamal, N Asem, M Hassany, G Elshishiney, W Abdel-Razek, H Said, ... The Lancet Gastroenterology & Hepatology 7 (7), 658-665, 2022 | 7 | 2022 |
| WHO awards Egypt with gold tier status on the path to eliminate hepatitis C M Hassany, W Abdel-Razek, M AbdAllah The Lancet Gastroenterology & Hepatology 8 (12), 1073-1074, 2023 | 6 | 2023 |
| Long-term clinical outcomes in sustained responders with chronic hepatitis C after treatment with direct-acting antivirals SA Alem, R Eletreby, Z Abdellatif, A Ramadan, A Nagy, M AbdAllah, ... European Journal of Gastroenterology & Hepatology 33 (1S), e746-e752, 2021 | 6 | 2021 |
| The prevalence and determinants of hepatitis B among Egyptian adults: a further analysis of a country-representative survey E Raslan, M AbdAllah, S Soliman Egyptian Liver Journal 12 (1), 46, 2022 | 5 | 2022 |
Aisha ElsharkawyViral Hepatitis Research Center, Al-Kasr Al-Aini Hospital, Cairo University在 cu.edu.eg 的电子邮件经过验证
